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CASE REPORT  
ANAESTHETIC MANAGEMENT OF NESIDIOBLASTOSIS IN TWO 
INFANTS 
Muhammad Saad Yousuf, Mohsin Nazir Butt, Fauzia Anis Khan 
Department of Anaesthesiology, Aga Khan University Hospital Karachi-Pakistan 
Nesidioblastosis is the most common cause of non-transient, recurrent and persistent 
hypoglycaemia in neonates and infants. It is a disorder of diffuse proliferation of beta cells of the 
pancreas leading to hyperinsulinemia and hypoglycaemia. The main aim is to prevent the severe 
episodes of hypoglycaemia which can cause damage to the brain and/or mental retardation. In this 
case report we present two cases of nesidioblastosis and their perioperative anaesthetic course for 
near-total pancreatectomy. First case was a 7 months old female who had repeated episodes of 
convulsions since birth. Second case was a 4-month-old female child who again presented with 
seizures. The challenges faced in the perioperative period were the management of perioperative 
blood glucose levels and haemodynamic stability. 
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INTRODUCTION 
Nesidioblastosis is a rare cause of hypoglycaemia in 
infancy due to unregulated over secretion of insulin.1 
Treatment varies from medical management to partial 
or subtotal pancreatectomy.2 Early diagnosis and 
prompt treatment are essential to prevent 
developmental delay and neurological damage. 
We present two cases of nesidioblastosis in 
infants with symptoms of severe hypoglycaemia 
associated with seizures, requiring surgical treatment. 
CASE REPORT 
Case 1: A seven months old female child weighing 
10.7 kg was admitted with repeated episodes of 
convulsions since day two of life associated with 
blood glucose level of 25 mg/dl. Physical 
examination and insulin level were normal. 
Ultrasonography of abdomen, renal and liver function 
tests were within normal limits. The infant was 
managed with intravenous (IV) half strength dextrose 
saline, two hourly feeds, levetiracetam 100 mg BID 
and somatostatin 50 mcg subcutaneously (S/C) 6 
hourly. She was scheduled electively for a near-total 
pancreatectomy. 
Intravenous infusion of half strength dextrose 
and all drugs was continued. Blood sugar was checked 
every 30 minutes using ACCU-Check blood glucose 
meter and remained between 80 and 150 mg/dl. 
Intraoperative monitoring included pulse oximetry, 
electrocardiogram, non-invasive blood pressure, end-
tidal carbon dioxide, temperature(oral), minimum 
alveolar concentration of inhalational agents, blood 
sugar and urine output. Bladder was catheterized and the 
urine output was measured.  
Induction of anaesthesia was done with IV 
morphine 0.1 mg/kg, Propofol 2 mg/kg and atracurium 
0.5 mg/kg. Trachea was intubated with size 4.0 mm 
uncuffed endotracheal tubes. Anaesthesia was 
maintained with a mixture of oxygen: air (50:50), and 
isoflurane 1.0–1.3%. A central venous cannula was then 
inserted in the right femoral vein. 
Half strength dextrose saline (50 ml/hr) was 
infused throughout. Blood sugar was estimated every 30 
minutes, which was between 64 and 380 mg/dl (Figure-
1). Surgery lasted two hours. Intraoperative 
haemodynamic parameters were stable and procedure 
was uneventful. Estimated blood loss was 10 ml. 
Atropine (0.02 mg/kg) and neostigmine (0.05 mg/kg) 
was administered, trachea was extubated and patient 
shifted to neonatal intensive care unit (NICU). 
Postoperative analgesia was provided by morphine 
infusion 0.2 mg/hr for next two days. 
In the NICU, there were multiple episodes of 
hypoglycaemia (as low as 42 mg/dl) but no fits. Twelve 
percent dextrose at the rate of 8 mg/kg/min was started 
along with somatostatin 20 mcg subcutaneously every 6 
hours and levetiracetam 100mg BID. After 48 hours, 
liquid diet was started 10 ml every 2 hourly and the 
blood sugar levels were stabilized around (50–260 
mg/dl) on oral feeds and half strength dextrose saline. 
Patient was discharged on the 16th postoperative day. 
Nesidioblastosis was reported in the histopathological 
specimen. 
Case 2: A four month old female infant weighing 5.7 kg 
was admitted with complaint of decreased oral intake, 
repeated episodes of convulsions and blood glucose 
level was 24 mg/dl. A genetic test for hyperinsulinemia 
revealed an autosomal recessive congenital 
hyperinsulinism. Management with intravenous 
dextrose 12% (20 ml/hr), somatostatin 40 mcg 
subcutaneously TID, diazoxide 25 ml per oral BID and 
levetiracetam 50 mg BID was started. A CT scan and 
ultrasound of the whole abdomen were normal. She was 
scheduled electively for a near-total pancreatectomy. 
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Intravenous infusion of 12% dextrose along with all the 
other drugs was continued. Blood sugar was checked 
two hourly by ACCU-Check blood glucose meter and 
was remained between 100 and 250 mg/dl. Anaesthesia 
was induced with sevoflurane and followed by IV 
morphine (0.1 mg/kg) and atracurium 0.5 mg/kg. 
Intraoperative monitoring was same as in previous 
patient. Trachea was intubated with size 3.0 mm 
uncuffed endotracheal tube. Anaesthesia was 
maintained with oxygen and air (50:50), isoflurane (1.0–
1.4%) and atracurium boluses. A central venous line 
was inserted in the right femoral vein. Dextrose solution 
(10% of 20 ml/hr) and Ringer’s lactate was 
administered at a rate of 10 ml/kg/hr. Blood sugar was 
estimated every 30 min, and ranged between 108 and 
280 mg/dl. Haemodynamic parameters were stable and 
procedure was uneventful. Estimated blood loss was 10 
ml. Atropine (0.02 mg/kg) and neostigmine (0.05 
mg/kg) was given to reverse the residual neuromuscular 
blockade. Atropine (0.02 mg/kg) and neostigmine (0.05 
mg/kg) was administered, trachea was extubated and 
patient shifted to NICU. Postoperative analgesia was 
provided by morphine infusion 0.1 mg/hr for next two 
days. 
She was initially hyperglycaemic, but later 
developed two episodes of hypoglycaemia (43 mg/dl 
and 50 mg/dl), for which 20 ml of 15% dextrose 
solution was infused slowly. Somatostatin was restarted 
at 15 mcg/kg/day. Her blood sugar levels were 
stabilized between 90 and 150 mg/dl. After one day, the 
patient’s condition remained stable. Mother’s feed of 30 
ml was then started every 2 hours with IV infusion of 
half strength dextrose saline at the rate of 5 ml/hr. The 
patient was discharged on the ninth post-operative day. 
Nesidioblastosis was reported in the histopathological 
resected specimen. Perioperative blood sugar 
management of both cases is shown in figure-1. 
 
Figure-1: Intraoperative blood sugar level in both 
patients 
DISCUSSION 
Nesidioblastosis is due to mutation in the genes 
regulating the function of the KATP channel located 
on the beta (cell membrane.3 The annual 
incidence of the sporadic form in infants is 1 in 
50,000 births.4 Glucose requirement of infants are 
two to four times that of adults due to relatively 
larger brain mass as compared to the total body mass 
and cerebral metabolism. 
Diagnostic features of hyperinsulinemia are; 
serum glucose level <60 mg/dl, non-ketotic 
hypoglycaemia associated with elevated insulin 
levels (>10 mU/ml) and sustained glucose 
requirement in excess of 10 mg/kg/min. 
EU glycaemia and prevention of brain injury from 
neuroglycopenia are the main goals of medical 
management. Timely nasogastric feeds, dextrose 
infusion (10–15%) and drugs like diazoxide, 
somatostatin or glucagon play an important role in 
medical management. Thiopentone has also been 
used in medical management.5 Phenytoin also inhibits 
release of insulin from beta-cells and hence may be 
helpful in the prevention of hypoglycaemia.6 
Both our children were receiving 
somatostatin which inhibits endocrine function of the 
normal pancreas. Somatostatin can inhibit growth 
hormone which causes poor growth, diarrhoea, 
vomiting and hepatic impairment leading to 
electrolyte disturbances. 
The goals for our anaesthetic management 
was to prevent intraoperative hypoglycaemia, avoid 
thiopentone for patients receiving diazoxide therapy 
and to maintain fluid shifts of major surgery. 
In hyperinsulinemia, the requirement of 
glucose increases to 10 mg/kg/min. When boluses of 
high concentration dextrose containing fluids are 
used, the blood glucose level could exceed renal 
threshold for glucose causing glycosuria and osmotic 
diuresis. Hence, it is preferable to use the dextrose 
containing fluid as maintenance and Ringer lactate as 
replacement solution. We use half strength dextrose 
saline (50ml/hr) as a maintenance fluid in our first 
case while using 10% dextrose (20 ml/hr) as 
maintenance fluid and Ringer’s lactate (10ml/kg/hr) 
as replacement solution in second case. 
Combination of epidural and general 
anaesthesia in infants also reduces the glucose 
requirement during surgery.7With the exception of 
desflurane, most of the volatile anaesthetics depresses 
the release of insulin and promote glucose 
intolerance.8 
After the pancreatic mass excision, rebound 
hyperglycaemia can occur but it is transient and is 
resolves spontaneously in most cases. Persistent 
rebound hyperglycaemia was not seen in our cases. 
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In summary, the successful anaesthetic management 
depends on the maintenance of normoglycemia, 
maintaining fluid management and stabilization of 
the haemodynamic throughout surgery. 
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